TOP STORIES

• REGULATORY Council Approves 80 Development Requests from 2nd Round
  March 27, 2012

• BUSINESS Epadel Generic in Short Supply at Sawai Pharmaceutical Due to Promotional Measures
  March 26, 2012

• BUSINESS Break of Day－Working to Optimize Settai Practices, Increase Financial Transparency: 3
  March 26, 2012

• BUSINESS Bayer Yakuhin to Initiate Drug Use-Result Survey on 10,000 Patients for Xarelto
  March 23, 2012

• BUSINESS Astellas Vice Deputy Chairman Ishii Says Company R&D Strategy Focused on Personalized Medicine
  March 22, 2012

• REGULATORY Council Meeting Considers Working Team to Explore Directions for Drug Distribution Improvement
  March 21, 2012

• ORGANIZATION Asia Partnership Conference Starts Talks for Early NDA Approval at Inauguration Meeting in Tokyo
  March 19, 2012

• BUSINESS Break of Day－Working to Optimize Settai Practices, Increase Financial Transparency: 1
  March 19, 2012

• BUSINESS Eli Lilly Japan Looks at Double-Digit Growth Despite Large Price Cuts in 2 Mainstay Drugs: President Zulueta
  March 16, 2012

• ORGANIZATION JPMA Compiles Policies for Transparency in Patient Group Relationships, Disclosure for States of Donations
  March 15, 2012

• BUSINESS Sawai’s Next Midterm Management Plan Aims to Create a “Muscular Company”: Pres. Sawai
  March 14, 2012

• BUSINESS Pfizer Reports 19% Boost in Sales in FY2011, “Continued Growth Possible” After Re-Pricing
  March 13, 2012

• REGULATORY Convincing Data Needed to Perpetuate Premium for New Drug Development: Mr Yoshida of MED
  March 13, 2012

• BUSINESS Sanofi-aventis Nichi-Iko Obtains Approval for Allegra Generic While Patent Dispute Continues
  March 12, 2012

• BUSINESS 20 Companies Review Risk Countermeasures After Earthquake, Novartis Looks into MR Standards of Behavior: Jiho Survey
  March 9, 2012

• BUSINESS Daiichi Sankyo to Integrate Global, Japan Business Management Functions into Four-Division Structure
  March 8, 2012

• ORGANIZATION Wholesale Industry FTC to “Watch Closely” How Drug Makers Respond to Tougher Rules on Business Entertaining
  March 7, 2012

• BUSINESS Eisai to See 11%+, Lilly Japan 8-9% Average Price Reduction in FY2012 NHI Price Revision: Jiho Survey
  March 6, 2012

• REGULATORY 702 Products Including DPP-4 Inhibitors to Be Eligible for New Drug Premium in April
  March 5, 2012

• REGULATORY Private-Sector Members of Strategy Council Call for Early Establishment of Drug Discovery Support Organization
  March 5, 2012

ページ

• « 先頭
• ‹ Prev
• …
• 239
• 240
• 241
• 242
• 243
• 244
• 245
• 246
• 247
• …
• Next ›
• 最終 »